drugset / Trial / NCT03407872
Safety and Pharmacokinetic Study of Inhaled Esketamine in Healthy Volunteers
Phase 1
Completed
63 enrolled
Celon Pharma SA
National Center for Research and Development, Poland · collab
RandomizedSequentialDouble-blindTreatment
Summary
The planned study is to determine the pharmacokinetic properties of Esketamine and safety assessment with inhaled Esketamine after different number of inhalations and different dosing sequences within three parts of the study.
Timeline
- Start
- 2017-12-09
- Primary completion
- 2018-05-20
- Completion
- 2018-06-19
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Esketamine | Other / unclassified | — | Inhaled |
Indications
No indication recorded.